These physicians are available for lectures and programs on hematology and oncology.
Sameem Abedin, MD, Assistant Professor of Medicine, Division of Hematology/Oncology
New and Emerging Therapies for Acute Myelogenous Leukemia
Treatment of MDS Beyond Hypomethylating Agents
Juliana Alvarez Argote, MD, Assistant Professor of Medicine
Benign Hematology
Sickle Cell Disease
Ehab Atallah, MD, Associate Professor of Medicine
Acute Lymphocytic Leukemia
Acute Mylegenous Leukemia
ALL: New therapies
AML: New therapies
Chronic Mylegenous Leukemia
CLL in the Era of Targeted Therapies
Molecular Monitoring and Treatment Free Remission in CML
Myelodysplastic Syndrome
Myelofibrosis
Update on Hematologic Malignancies
What PCPs Should Know About Leukemia
John Charlson, MD, Associate Professor of Medicine
Management of Soft Tissue Sarcoma
Lubna Chaudhary, MD, MS, Associate Professor of Medicine; Associate Program Director, Fellowship Program
Endocrine Resistance in Luminal Breast Cancers
Management of HER2+ Breast Cancers
Yee Chung Cheng, MD, MS, Associate Professor
Inflammatory Breast Cancer
Triple Negative Breast Cancer
Michael Deininger, MD, PhD, Professor
Chronic Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Hyperesinophilic Syndromes
Myeloproliferative Neoplasms
Systemic Mastocytosis
Sumana Devata, MD, Associate Professor, Section Chief Hematology/Oncology, Milwaukee VA Health System
Diffuse Large B-Cell Lymphoma
Hodgkin Lymphoma
Updates in Diffuse Large B-Cell Lymphoma
Anita D’Souza, MD, MS, Associate Professor of Medicine
Amyloidosis
Light Chain Amyloidosis: Strategies to Improve Outcomes
Paraneoplastic Monoclonal Gammopathy of Undetermined Significance Conditions
Recent Advances in AL Amyloidosis
Recent Advances in Multiple Myeloma
Work-Up of Monoclonal Gammopathy of Undetermined Significance
Tim Fenske, MD, Professor of Medicine
Advances in Non-Hodgkin Lymphoma
Recent Advances in Hodgkin Lymphoma
Recent Advances in Stem Cell Transplantation for Lymphoma
Patrick Foy, MD, Associate Professor
Anticoagulation
Hemolytic Anemia
Thrombocytopenia
Mehdi Hamadani, MD, Professor of Medicine
CAR-T Treatment for Lymphomas
Current State of Transplantation of Lymphomas
Hodgkin Lymphoma: State of the Art
Modern Management of Diffuse Large B-Cell Lymphoma
Mandana Kamgar, MD, MPH, Assistant Professor of Medicine
Targeting DNA Damage Repair in Pancreatic Ductal Adenocarcinoma
Targeting Kras in Pancreatic Ductal Adenocarcinoma
Razelle Kurzrock, MD, FACP, Professor of Medicine
Precision Medicine
Rare Cancers
Laura C. Michaelis, MD, Associate Professor of Medicine
Acute Myelogenous Leukemia
Myelodysplastic Syndromes
Myeloproliferative Diseases
Novel Chemotherapies in Blood Cancers
Update on Hematologic Malignancies
What PCPs Should Know About Leukemia
Ravi Kishore Narra, MD, Assistant Professor
Malignant Hematology (Acute and Chronic Leukemias, MDS, MPN, Plasma Cell Disorders)
Ariel Nelson, MD, Assistant Professor of Medicine
Management of Advanced Bladder Cancer
Management of Advanced Renal Cell Carcinoma
Juliana Perez Botero, MD, Medical Director, Molecular Oncology and Genetics Laboratory (MOGL); Assistant Investigator, Blood Research Institute; Assistant Professor
Genetic Diagnosis of Non-Malignant Hematologic Disorders
Hematologic Disorders in Pregnancy
Inherited and Acquired Thrombocytopenia
Lyndsey Runaas, MD, Assistant Professor of Medicine
AML: Updates in Management
Bone Marrow Transplant: What a Primary Care Provider Should Know
MDS: Diagnosis and Treatment
Nirav Shah, MD, MS, Associate Professor of Medicine
CAR T-Cells for B-Cell Malignancies
Frontline Management of DLBCL
Updates in Follicular Lymphoma
James Thomas, MD, PhD, Professor of Medicine
Cancer Clinical Trials
Cancer Drug Development
Colorectal Cancer
Gastrointestinal Cancers
Neuroendocrine Cancers
Jonathan Thompson, MD, MS, Assistant Professor of Medicine
Advances in Immunotherapies for Solid Tumors
Immunotherapy for Non-Small Cell Lung Cancer
Immunotherapy Toxicity
Management of Malignant Pleural Mesothelioma
Management of Small Cell Lung Cancer
Multidisciplinary Care of Lung Cancer
Targeted Therapies for Non-Small Cell Lung Cancer